Monthly Prescribing Reference

Pneumococcal Vaccine Schedule: High Risk Pediatrics

1 dose ≥8wks after last PCV dose 12 No additional vaccine 6 PCV15 or PCV20 1 dose ≥8wks after last pneumococcal vaccine 8 If PCV15 used, also give PPSV23 ≥8wks after the last PCV dose if not ...
Monthly Prescribing Reference

Pneumococcal 21-Valent Conjugate Vaccine Elicits Immune Response in Children at Increased Risk

Findings showed Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines. Topline data were announced from a phase 3 trial evaluating Merck’s 21-valent ...
Healio

Vaccination, prophylaxis recommended for children with primary immunodeficiencies

Please provide your email address to receive an email when new articles are posted on . Two doses of PPSV23 5 years apart are recommended. Stratifying T-cell deficiencies can help ensure safe ...
Infectious Disease Advisor

HIV-Specific Vaccine Adherence Is Suboptimal in Pediatric Patients

Study results indicate suboptimal adherence to HIV-specific immunization recommendations among pediatric patients receiving ...
Benzinga.com

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...